At the fourth stage (Stabilization), it adds Nicotinamide Adenine Dinucleotide (NAD+) as an extra support piece tied to inflammation and body changes
Why are GLP-1 receptor agonists in short supply? British Journal of Diabetes (2022)
Understanding this trajectory helps explain why early intervention matters and how Retatrutide can alter the course
In the Phase 3 trials, adults taking retatrutide 12mg lost an average of 28.7% of their body weight after 68 weeks
Be sure to include the brand name, dose, route, frequency, and indication of each GLP-1 agonist medication, if applicable
Since insulin therapy often indicates more advanced disease progression, greater severity, or additional comorbidities, which may lead to a higher risk of intestinal obstruction, and there was no statistically significant difference in intestinal obstruction risk between GLP-1RAs and other anti-diabetic medications (e.g., SGLT2 inhibitors, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors), the observed reduction relative to insulin does not necessarily suggest a protective effect of GLP-1RAs against intestinal obstruction
